BPC-157 research vial
Sequence length
15 AA
Molecular weight
1419.53 g/mol
Current batch
BPC15202601
Regenerative · Cellular repair / Tendon and tissue research

BPC-157

Pentadecapeptide fragment derived from a gastric protective protein

BPC-157 (10mg vials)

Sign up for verified researcher access to view pricing, see in-stock quantity, and order at member volume tiers (up to 20% off at 20+ vials).

Sign up to view pricing and order.Verified researchers only. Active immediately on sign-up.
Apply for access →

Specifications

Molecular weight1419.53 g/mol
Sequence length15 amino acids
Amino acid sequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
AppearanceWhite lyophilized powder
SolubilityBacteriostatic water; sterile water
Storage (lyophilized)-20°C, protected from light
Storage (reconstituted)2–8°C, use within 28 days
Half-lifeShort systemic half-life; enhanced stability noted in in vivo studies
Current batch purity99.75% (HPLC) · BPC15202601

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide originally identified as a partial sequence of a gastric protective protein. The 15-amino-acid sequence (GEPPPGKPADDAGLV) is widely studied in vitro and in animal models for its effects on cellular repair pathways, angiogenesis, and tendon fibroblast biology. BPC-157 is supplied by NovaWell as a lyophilized powder, third-party tested for purity and endotoxin conformance, for laboratory research use only.

Research Studies

The following studies are summarized for educational purposes only. Inclusion does not imply any human use; all referenced research was conducted in vitro or in animal models.

Research study

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts

Chang CH, Tsai WC, Hsu YH, Pang JH. Molecules. 2014;19(11):19066–77. View source ↗

Scientific findings

This in vitro study examined the effect of BPC-157 on isolated rat Achilles tendon fibroblasts. The researchers reported a dose- and time-dependent upregulation of growth hormone receptor (GHR) expression at both the mRNA and protein level following BPC-157 exposure. The functional consequence — increased proliferation in the presence of growth hormone — was demonstrated via MTT proliferation assay and PCNA expression. Co-exposure to growth hormone activated the JAK2 signaling pathway downstream of the GHR, consistent with sensitization of tendon fibroblasts to anabolic signaling. The authors propose that BPC-157's reported effects on tendon repair in animal models may be partly mediated by this GHR-axis modulation.

Plain English

Scientists studied how BPC-157 affects tendon cells in a laboratory dish. They found that BPC-157 increases the number of "docking sites" on tendon cells where the body's natural growth hormone can attach. With more docking sites available, tendon cells respond more strongly to growth hormone and grow faster. This may help explain why BPC-157 has been associated with tendon healing in animal studies — it appears to make tendon cells more responsive to a natural repair signal the body already produces.

Research study

Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JH. J Mol Med (Berl). 2017;95(3):323–333. View source ↗

Scientific findings

This combined in vitro and in vivo study investigated the angiogenic mechanism of BPC-157. In human umbilical vein endothelial cells (HUVECs), BPC-157 increased capillary-like tube formation and was associated with upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) at both mRNA and protein levels. The peptide promoted VEGFR2 internalization — a step required for downstream activation — and triggered time-dependent phosphorylation of the VEGFR2-Akt-eNOS axis. In an animal model of leg ischemia, BPC-157 administration was associated with increased blood vessel density in the affected limb, consistent with the in vitro findings.

Plain English

Researchers looked at how BPC-157 affects the cells that line blood vessels. They found that BPC-157 acts like a switch that tells these cells to grow new blood vessels. It does this by amplifying a signal pathway the body already uses for vessel growth. In a mouse model where blood flow to a leg was restricted, BPC-157 was associated with more new blood vessels forming. New blood vessels can deliver more oxygen and nutrients to injured tissue, which is one mechanism by which BPC-157 may support repair in animal studies.

Storage & handling

Lyophilized (unreconstituted): Store at -20°C, protected from light. Stable for 24+ months under correct storage. Avoid repeated temperature cycling.

Reconstituted: Dissolve in bacteriostatic water (typically 1–2 mL per 10 mg vial, depending on the research protocol). Store reconstituted solution at 2–8°C and use within 28 days. Do not freeze reconstituted solution.

Vial format: 10 mg lyophilized, vacuum-sealed glass vial with rubber stopper and aluminum crimp. Sterility tested per USP guidelines.

Shipping: Lyophilized BPC-157 is stable at ambient temperature for the typical 1–3 day shipping window. Cold-pack shipping available on request.

Frequently asked questions

What peptide sequence is BPC-157?+

BPC-157 is the 15-amino-acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), with a molecular weight of approximately 1419.53 g/mol. It is a synthetic fragment originally derived from a gastric protective protein identified in human gastric juice.

What does NovaWell test BPC-157 for?+

Every batch of BPC-157 supplied by NovaWell is tested by an independent third-party laboratory for: identity and purity (HPLC + MS), bacterial endotoxin (USP <85>), heavy metals (USP), and sterility (USP). The Certificate of Analysis for the currently shipping batch is linked from the Certificates tab on this page.

What is the purity of your current BPC-157 batch?+

Our current shipping batch is documented in the Certificates tab on this page, along with the test date, manufacturer ID, and the independent laboratory that performed the analysis. Recent batches have tested above 99.5% pure by HPLC.

How should BPC-157 be stored after reconstitution?+

Once reconstituted in bacteriostatic water, BPC-157 should be stored at 2–8°C and used within 28 days. Do not freeze reconstituted solution. The lyophilized powder is stable at -20°C for 24+ months.

Where does NovaWell source BPC-157?+

NovaWell sources BPC-157 from a vetted synthesis partner under our supplier qualification protocol, which includes facility audits and review of internal QC documentation. Every batch is then independently verified by a third-party laboratory before release. The manufacturer ID for the currently shipping batch is listed in the Description tab.

What's the difference between BPC-157 and TB-500?+

BPC-157 and TB-500 (Thymosin Beta-4) are structurally unrelated peptides studied for different mechanisms. BPC-157 (15 amino acids) has been studied in animal models for tendon and tissue repair via GHR and VEGFR2 pathways. TB-500 (43 amino acids, full-length Thymosin Beta-4) has been studied for actin regulation, cell migration, and angiogenesis. Some researchers combine them in a single formulation; see our BPC-157 + TB-500 Blend.

Is BPC-157 stable in shipping?+

Lyophilized BPC-157 is stable at ambient temperature for the standard 1–3 day shipping window. Long-term storage requires -20°C. We offer cold-pack shipping on request for any researcher whose protocol requires it.